Progyny (PGNY) Competitors $14.34 +0.15 (+1.06%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PGNY vs. SHC, AGL, VMD, CO, MRAI, BRTX, OTRK, MGRX, NIVF, and GBNHFShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Sotera Health (SHC), agilon health (AGL), Viemed Healthcare (VMD), Global Cord Blood (CO), Marpai (MRAI), BioRestorative Therapies (BRTX), Ontrak (OTRK), Mangoceuticals (MGRX), NewGenIvf Group (NIVF), and Greenbrook TMS (GBNHF). These companies are all part of the "miscellaneous health & allied services, not elsewhere classified" industry. Progyny vs. Sotera Health agilon health Viemed Healthcare Global Cord Blood Marpai BioRestorative Therapies Ontrak Mangoceuticals NewGenIvf Group Greenbrook TMS Sotera Health (NASDAQ:SHC) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations. Which has better earnings and valuation, SHC or PGNY? Progyny has higher revenue and earnings than Sotera Health. Progyny is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSotera Health$1.12B3.35$51.38M$0.2552.96Progyny$1.14B1.07$62.04M$0.5824.72 Does the media prefer SHC or PGNY? In the previous week, Sotera Health had 1 more articles in the media than Progyny. MarketBeat recorded 6 mentions for Sotera Health and 5 mentions for Progyny. Progyny's average media sentiment score of 1.02 beat Sotera Health's score of 0.46 indicating that Progyny is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Progyny 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in SHC or PGNY? 91.0% of Sotera Health shares are held by institutional investors. Comparatively, 94.9% of Progyny shares are held by institutional investors. 55.1% of Sotera Health shares are held by insiders. Comparatively, 12.3% of Progyny shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in SHC or PGNY? Progyny received 51 more outperform votes than Sotera Health when rated by MarketBeat users. Likewise, 71.43% of users gave Progyny an outperform vote while only 57.65% of users gave Sotera Health an outperform vote. CompanyUnderperformOutperformSotera HealthOutperform Votes4957.65% Underperform Votes3642.35% ProgynyOutperform Votes10071.43% Underperform Votes4028.57% Is SHC or PGNY more profitable? Sotera Health has a net margin of 6.31% compared to Progyny's net margin of 5.03%. Sotera Health's return on equity of 42.27% beat Progyny's return on equity.Company Net Margins Return on Equity Return on Assets Sotera Health6.31% 42.27% 6.02% Progyny 5.03%11.36%7.87% Do analysts rate SHC or PGNY? Sotera Health presently has a consensus target price of $16.08, indicating a potential upside of 21.48%. Progyny has a consensus target price of $25.00, indicating a potential upside of 74.34%. Given Progyny's higher possible upside, analysts clearly believe Progyny is more favorable than Sotera Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sotera Health 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Progyny 0 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.31 Which has more risk & volatility, SHC or PGNY? Sotera Health has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500. SummaryProgyny beats Sotera Health on 9 of the 17 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.21B$1.91B$5.13B$9.07BDividend YieldN/A7.04%5.08%4.23%P/E Ratio24.7215.5789.5817.17Price / Sales1.073.171,116.12116.95Price / Cash21.779.7742.8237.86Price / Book2.493.044.774.78Net Income$62.04M$69.56M$120.15M$225.60M7 Day Performance-1.85%-1.73%-1.92%-1.23%1 Month Performance-4.21%-2.76%11.47%3.36%1 Year Performance-62.04%-25.02%30.54%16.60% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny4.0397 of 5 stars$14.34+1.1%$25.00+74.3%-60.6%$1.21B$1.14B24.72563Positive NewsHigh Trading VolumeSHCSotera Health3.5856 of 5 stars$12.99-1.2%$16.08+23.8%-20.0%$3.68B$1.05B52.603,000Positive NewsAGLagilon health2.3096 of 5 stars$2.22-0.9%$4.28+92.9%-84.0%$914.68M$5.59B-2.381,117Gap DownVMDViemed Healthcare1.7209 of 5 stars$8.67-0.8%N/A+3.6%$337.61M$183.01M32.37630Positive NewsCOGlobal Cord BloodN/A$1.26flatN/A-16.7%$153.15M$1.24B4.671,202MRAIMarpaiN/A$1.11-11.2%$6.00+440.5%-47.7%$15.25M$34.87M-0.42150Gap DownBRTXBioRestorative Therapies3.455 of 5 stars$1.45flat$18.00+1,141.4%-11.4%$10.03M$150,000.00-0.917OTRKOntrak2.6135 of 5 stars$1.60-2.4%$45.00+2,712.5%-76.2%$6.75M$11.24M-0.15250Positive NewsMGRXMangoceuticals1.1789 of 5 stars$2.55-2.3%N/A-96.2%$6.34M$755,000.00-0.453News CoverageGap UpNIVFNewGenIvf Group0.4995 of 5 stars$0.28-11.3%N/AN/A$1.05M$5.14M0.00N/AGap DownGBNHFGreenbrook TMSN/A$0.01-18.0%N/AN/A$408,000.00$73.79M-0.01430Gap Up Related Companies and Tools Related Companies Sotera Health Alternatives agilon health Alternatives Viemed Healthcare Alternatives Global Cord Blood Alternatives Marpai Alternatives BioRestorative Therapies Alternatives Ontrak Alternatives Mangoceuticals Alternatives NewGenIvf Group Alternatives Greenbrook TMS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PGNY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
